{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:10:20Z","timestamp":1788311420158,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["32125037"],"award-info":[{"award-number":["32125037"]}],"id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007925","name":"Huazhong Agricultural University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFD1801102"],"award-info":[{"award-number":["2021YFD1801102"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Microbiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.vetmic.2023.109781","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T11:30:07Z","timestamp":1684755007000},"page":"109781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Better therapeutic effect of oral administration of GS441524 compared with GC376"],"prefix":"10.1016","volume":"283","author":[{"given":"Yuanyuan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetmic.2023.109781_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/AAC.49.2.560-564.2005","article-title":"Pharmacokinetics of the antiviral agent beta-L-3\u2032-fluoro-2\u2032,3\u2032-didehydro-2\u2032,3\u2032-dideoxycytidine in rhesus monkeys","volume":"49","author":"Asif","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.vetmic.2023.109781_bib2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/jac\/dkaa472","article-title":"Remdesivir and GS-441524 plasma concentrations in patients with end-stage renal disease on haemodialysis","volume":"76","author":"Davis","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.vetmic.2023.109781_bib3","first-page":"10","article-title":"Feline coronavirus antivirals: a review","author":"Delaplace","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.vetmic.2023.109781_bib4","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vetmic.2023.109781_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105081","article-title":"GS-441524 inhibits African swine fever virus infection in vitro","volume":"191","author":"Huang","year":"2021","journal-title":"Antivir. Res"},{"key":"10.1016\/j.vetmic.2023.109781_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cts.12840","article-title":"Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID-19, in healthy subjects","volume":"13","author":"Humeniuk","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.vetmic.2023.109781_bib7","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1128\/JVI.01348-12","article-title":"Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.vetmic.2023.109781_bib8","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1021\/acs.jmedchem.0c01929","article-title":"Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models","volume":"65","author":"Li","year":"2022","journal-title":"J. Med Chem."},{"key":"10.1016\/j.vetmic.2023.109781_bib9","article-title":"The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants.pdf","author":"Liu Cao","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.vetmic.2023.109781_bib10","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/s41467-022-29413-2","article-title":"Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vetmic.2023.109781_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112711","article-title":"The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020","volume":"206","author":"Liu","year":"2020","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.vetmic.2023.109781_bib12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.addr.2013.01.001","article-title":"Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview","volume":"65","author":"Mignani","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vetmic.2023.109781_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet. Microbiol"},{"key":"10.1016\/j.vetmic.2023.109781_bib14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1098612X17729626","article-title":"Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis","volume":"20","author":"Pedersen","year":"2018","journal-title":"J. Feline Med. Surg."},{"key":"10.1016\/j.vetmic.2023.109781_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1098612X19825701","article-title":"Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis","volume":"21","author":"Pedersen","year":"2019","journal-title":"J. Feline Med Surg."},{"key":"10.1016\/j.vetmic.2023.109781_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2019.108398","article-title":"Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor","volume":"237","author":"Perera","year":"2019","journal-title":"Vet. Microbiol"},{"key":"10.1016\/j.vetmic.2023.109781_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41564-022-01119-7","article-title":"An orally available M(pro) inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron","volume":"7","author":"Quan","year":"2022","journal-title":"Nat. Microbiol"},{"key":"10.1016\/j.vetmic.2023.109781_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jfms.2011.01.008","article-title":"Development of monoclonal antibodies (MAbs) to feline interferon (fIFN)-gamma as tools to evaluate cellular immune responses to feline infectious peritonitis virus (FIPV)","volume":"13","author":"Satoh","year":"2011","journal-title":"J. Feline Med Surg."},{"key":"10.1016\/j.vetmic.2023.109781_bib19","article-title":"RoboCap:Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract","author":"Shriya S. Srinivasan","year":"2022","journal-title":"Sci. Robot."},{"key":"10.1016\/j.vetmic.2023.109781_bib20","doi-asserted-by":"crossref","first-page":"eabp9066","DOI":"10.1126\/scirobotics.abp9066","article-title":"RoboCap: robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract","volume":"7","author":"Srinivasan","year":"2022","journal-title":"Sci. Robot."},{"key":"10.1016\/j.vetmic.2023.109781_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2007.02.006","article-title":"TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages","volume":"364","author":"Takano","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vetmic.2023.109781_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.aivir.2016.08.002","article-title":"Feline coronaviruses: pathogenesis of feline infectious peritonitis","volume":"96","author":"Tekes","year":"2016","journal-title":"Adv. Virus Res"},{"key":"10.1016\/j.vetmic.2023.109781_bib23","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1016\/j.bmcl.2011.07.016","article-title":"Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease","volume":"21","author":"Tiew","year":"2011","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.vetmic.2023.109781_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113584","article-title":"Improved SARS-CoV-2 M(pro) inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies","volume":"222","author":"Vuong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.vetmic.2023.109781_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00745-21","article-title":"Establishment of full-length cDNA clones and an efficient oral infection model for feline coronavirus in cats","volume":"95","author":"Wang","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.vetmic.2023.109781_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116364","article-title":"Potency and pharmacokinetics of GS-441524 derivatives against SARS-CoV-2","volume":"46","author":"Wei","year":"2021","journal-title":"Bioorg. Med Chem."},{"key":"10.1016\/j.vetmic.2023.109781_bib27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.apsb.2021.03.028","article-title":"Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment","volume":"11","author":"Xie","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.vetmic.2023.109781_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/v12020240","article-title":"Structural basis for inhibiting porcine epidemic diarrhea virus replication with the 3C-like protease inhibitor GC376","volume":"12","author":"Ye","year":"2020","journal-title":"Viruses"}],"container-title":["Veterinary Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378113523001335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378113523001335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T23:21:37Z","timestamp":1759879297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378113523001335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":28,"alternative-id":["S0378113523001335"],"URL":"https:\/\/doi.org\/10.1016\/j.vetmic.2023.109781","relation":{},"ISSN":["0378-1135"],"issn-type":[{"value":"0378-1135","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Better therapeutic effect of oral administration of GS441524 compared with GC376","name":"articletitle","label":"Article Title"},{"value":"Veterinary Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetmic.2023.109781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109781"}}